ReviewCancers2022
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors.
Xavier Thuru et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewCancers2022
Xavier Thuru et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.